Get started
KADIMASTEMKADIMASTEMKADIMASTEM

KADIMASTEM

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

KDST fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Kadimastem Ltd. engages in developing cell therapy in the field of regenerative medicine. It develops a platform for the development and production of embryonic stem cells and various engineered pluripotent stem cells for the purpose of developing cell drugs as off-the-shelf products in the field of regenerative medicine. The company was founded by Yossi Ben Yosef and Michel Revel on October 6, 2008 and is headquartered in Ness Ziona, Israel.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
KDST has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company